Nevertheless, to fully establish the tumour-specific isoform and also key molecular and biophysical features of HERG1 deregulation in the different cancers would be fundamental as it will undoubtedly open new avenues for therapeutic strategies to target specifically and effectively HERG1 oncogenic properties. Here, KCNH2 is linked to cancer.